跳至主要内容
临床试验/NCT06233604
NCT06233604招募中4 期

Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Hip Arthroplasty

Poznan University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年4月10日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
30
试验地点
1
主要终点
first need of opiate

研究概览

简要总结

Effect of perineurial dexamethasone and dexmedetomidine on erector spinal plane block duration for hip arthroplasty

详细描述

This study is proposed to explore the effect of perineurial Dexamethasone and Dexmedetomidine on erector spinal plane block duration for spine surgery.

After spine surgery, patients need good analgesia. Peripheral nerve blocks have provided a safe, effective method to control early postoperative pain when symptoms are most severe.

The safety of local anaesthesia is essential due to the much lower toxicity threshold of local anaesthetics. An effective adjuvant, such as Dexamethasone or Dexmedetomidine, could allow for a higher dilution of local anaesthetics while maintaining and enhancing their analgesic effect.

There is considerable research where intravenous and perineural dexamethasone and Dexmedetomidine use have been compared in adults. However, there is a massive lack of research regarding spine surgery and the Erector Spinae Plane Block.

In this study, investigators compare perineural Dexamethasone and Dexmedetomidine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients undergoing primary hip arthroplasty
  • aged >18 years and <100 years
  • ASA physical status 1, 2 or 3.

排除标准

  • if they refused to participate,
  • had a history of opioid abuse,
  • had an infection of the site of needle puncture,
  • were less than 18 years of age,
  • were postponed as having ASA 4 or 5,
  • had an allergy to any of the drugs used in the study,
  • renal failure (estimated glomerular filtration rate <15ml/min/1.73m2),
  • liver failure,
  • known or suspected coagulopathy,
  • pre-existing anatomical or neurological disorders in the lower extremities,
  • intellectual disability with problems in pain evaluation,
  • severe psychiatric illness.

研究组 & 干预措施

Placebo

Placebo Comparator

0.2% ropivacaine for erector spinae plane block

干预措施: 0.9%sodium chloride (Drug)

Dexamethasone

Experimental

0.2% ropivacaine + 4mg Dexamethasone for erector spinae plane block

干预措施: Dexamethasone (Drug)

Dexmedetomidine

Experimental

0.2% ropivacaine + 50ug Dexmedetomidine for erector spinae plane block

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

first need of opiate

时间窗: 48 hours after surgery

Time after surgery when the patient needs opiate for the first time

次要结局

  • NLR(48 hours after surgery)
  • PLR(48 hours after surgery)
  • Numerical Rating Scale [range 0:10](24 hours after surgery)
  • Opioid consumption(48 hours after surgery)

研究者

发起方
Poznan University of Medical Sciences
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验